L. Bertoletti (Saint Etienne Cedex, France), S. Ramjug (Altrincham, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Venous thromboembolism associated with reduced lung function, dyspnoea and asthma in the general population K. Nilausen (Køge, Denmark), E. Landt (Køge, Denmark), S. Al-Shuweli (Køge, Denmark), U. Bødtger (Næstved, Denmark), B. Nordestgaard (Herlev, Denmark), M. Dahl (Køge, Denmark)
|    |
A case-control study on direct oral anticoagulants versus warfarin for acute pulmonary embolism in obese patients C. Samaranayake (London, United Kingdom), C. Mccabe (London, United Kingdom), S. Slader (Brisbane, Australia), T. Tseng (Brisbane, Australia), K. Tran (Brisbane, Australia), J. Anderson (Brisbane, Australia), L. Price (London, United Kingdom), S. Wort (London, United Kingdom), A. Mccann (Brisbane, Australia), G. Keir (Brisbane, Australia), J. Upham (Brisbane, Australia)
|    |
Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD E. Rastoder (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), M. Saeed (Hellerup, Denmark), A. Svorre Jordan (Hellerup, Denmark), H. Meteran (Hellerup, Denmark), L. Tønnesen (Hellerup, Denmark), T. Biering-Sørensen (Hellerup, Denmark), A. Løkke (Aarhus, Denmark), N. Seershol (Copenhagen, Denmark), T. Lynghøj Nielsen (Hillerød, Denmark), J. Carlsen (Copenhagen, Denmark), J. Janner (Copenhagen, Denmark), N. Godtfredsen (Copenhagen, Denmark), U. Bødtger (Naestved, Denmark), C. Laursen (Odense, Denmark), O. Hilberg (Vejle, Denmark), F. Knop (Hellerup, Denmark), H. Priemé (Herlev, Denmark), V. Gottlieb (Hellerup, Denmark), J. Wilcke (Hellerup, Denmark), J. Stæhr Jensen (Hellerup, Denmark)
|    |
The role of uric acid to creatinine ratio as predictor marker during pulmonary embolism K. Bartziokas (Ioannina, Greece), C. Kyriakopoulos (Ioannina, Greece), A. Gogali (Ioannina, Greece), D. Potonos (Ioannina, Greece), K. Exarchos (Ioannina, Greece), C. Chronis (Ioannina, Greece), K. Kostikas (Ioannina, Greece)
|    |
Comparison of Septic and Non-Septic Pulmonary Embolism in Children D. Gatt (Beer Sheva, Israel), S. Ben Shimol (Beer Sheva, Israel), G. Hazan (Beer Sheva, Israel), I. Golan Tripto (Beer Sheva, Israel), A. Goldbart (Beer Sheva, Israel), M. Aviram (Beer Sheva, Israel)
|    |
Post-COVID-19 patients show an increased endothelial progenitor cell production P. Poyatos (Girona, Spain), N. Luque (Girona, Spain), L. Sebastián (Girona, Spain), M. Bonnin (Girona, Spain), S. Eizaguirre (Girona, Spain), G. Sabater (Girona, Spain), M. Boixadé (Girona, Spain), R. Orriols (Girona, Spain), O. Tura-Ceide (Girona, Spain)
|    |
Right ventricular assist devices for mechanical circulatory support in acute massive pulmonary embolism: a single centre experience C. Samaranayake (London, United Kingdom), B. Garfield (London, United Kingdom), S. Seitler (London, United Kingdom), S. Davies (London, United Kingdom), S. Ledot (London, United Kingdom), C. Mccabe (London, United Kingdom), S. Wort (London, United Kingdom), S. Price (London, United Kingdom), L. Price (London, United Kingdom), R. Trimlett (London, United Kingdom)
|    |
Pulmonary Embolism: Incidence, spectrum of CTPA findings, and correlation of D-dimers with embolus location. Is age-adjusted D-dimers cutoff a better screening method? S. Chrysikos (Athens, Greece), O. Papaioannou (Patra, Greece), T. Karampitsakos (Patra, Greece), M. Anyfanti (Athens, Greece), G. Hillas (Athens, Greece), K. Tavernaraki (Athens, Greece), A. Tzouvelekis (Patra, Greece), K. Dimakou (Athens, Greece), L. Thanos (Athens, Greece)
|    |
Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism A. Partridge (Calgary, Alberta, Canada), P. Boiteau (Calgary, Alberta, Canada), J. Andruchow (Calgary, Alberta, Canada), A. Ferland (Calgary, Alberta, Canada), E. Herget (Calgary, Alberta, Canada), D. Helmerson (Calgary, Alberta, Canada), J. Weatherald (Calgary, Alberta, Canada), K. Solverson (Calgary, Alberta, Canada)
|    |
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19 A. Bekki (València (Comunidad Valenciana), Spain), A. García-Ortega (València (Comunidad Valenciana), Spain), G. Oscullo (València (Comunidad Valenciana), Spain), P. Calvillo (València (Comunidad Valenciana), Spain), R. Méndez (València (Comunidad Valenciana), Spain), J. Gómez-Olivas (València (Comunidad Valenciana), Spain), C. Fonfría (València (Comunidad Valenciana), Spain), L. Trilles-Olasco (València (Comunidad Valenciana), Spain), E. Zaldívar (València (Comunidad Valenciana), Spain), A. Ferrando (València (Comunidad Valenciana), Spain), G. Anguera (València (Comunidad Valenciana), Spain), A. Briones-Gómez (València (Comunidad Valenciana), Spain), J. Reig-Mezquida (València (Comunidad Valenciana), Spain), L. Feced (València (Comunidad Valenciana), Spain), P. González-Jiménez (València (Comunidad Valenciana), Spain), S. Reyes (València (Comunidad Valenciana), Spain), C. Muñoz-Nuñéz (València (Comunidad Valenciana), Spain), A. Carreres (València (Comunidad Valenciana), Spain), R. Gil (València (Comunidad Valenciana), Spain), C. Morata (València (Comunidad Valenciana), Spain), R. López-Reyes (València (Comunidad Valenciana), Spain), L. Martí-Bonmatí (València (Comunidad Valenciana), Spain), R. Menéndez (València (Comunidad Valenciana), Spain), M. Martínez-García (València (Comunidad Valenciana), Spain)
|    |
Discussion
|  |